On October 30, Stryker fell 10.83% in Pre-Market Trading, trading at $278.88 per share, with turnover of $84.9 thousand.
The move followed the company’s latest quarterly results and guidance update: third-quarter adjusted EPS came in at $3.52 versus the $3.55 consensus, while revenue was $6.52 billion versus the $6.62 billion expected.
More importantly, Stryker lowered its full-year adjusted EPS outlook to $14.80 to $14.90 from the prior $14.95 to $15.10 range, signaling softer-than-expected earnings delivery. The company also expanded its share repurchase authorization by $3 billion, but that was not enough to offset the negative reaction to the earnings miss and guidance cut.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments